Nicolas Wein

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation”.

X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation

Skeletal Muscle(2020)10.1186/s13395-020-00239-0

N/A

0DataRank · unranked

21 citations

Nadège Calmels, Robert B. Weiss, Laurent Tiret, Adeline Vulin, Nicolas Wein +13 more

X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterization.

Research Square(2020)10.21203/rs.3.rs-16251/v2

N/A

0DataRank · unranked

0 citations

Nadège Calmels, Robert B. Weiss, Laurent Tiret, Adeline Vulin, Nicolas Wein +13 more

X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterization.

Research Square(2020)10.21203/rs.3.rs-16251/v1

N/A

0DataRank · unranked

0 citations

Nadège Calmels, Robert B. Weiss, Laurent Tiret, Adeline Vulin, Nicolas Wein +13 more

Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders

Journal of Personalized Medicine(2022)10.3390/jpm12121979

N/A

0DataRank · unranked

22 citations

Megan Baird, M. Schwartz, Smita Saxena, Kathrin Meyer, Nicolas Wein +1 more

Mechanisms of IRF2BPL-related disorders and identification of a potential therapeutic strategy

Cell Reports(2022)10.1016/j.celrep.2022.111751

N/A

0DataRank · unranked

17 citations

Debdeep Dutta, Cassandra N. Dennys, Samantha K. Powers, Florence Roussel, Paweł Lisowski +12 more

Persistence of exon 2 skipping and dystrophin expression at 18 months after U7snRNA-mediated therapy in the Dup2 mouse model

Molecular Therapy — Methods & Clinical Development(2023)10.1016/j.omtm.2023.101144

N/A

0DataRank · unranked

17 citations

A. Bradley, Tatyana A. Vetter, Jacob W. Lay, N. Rohan, E. Frair +3 more

Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200908

N/A

0DataRank · unranked

7 citations

Akila S. Venkataramany, Matías Montes, John F. Kipp, Ryan D. Roberts, Nicolas Wein +5 more